TONIX PHARMACEUTICALS HOLDING CORP. Stock-Based Compensation
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Stock-Based Compensation of $4.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.26M, a 58.54% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.97M, a 123.36% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.79M, a 100.11% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.92M, a 85.26% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for fiscal 2025 was $6.02M, a 25.93% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for fiscal 2024 was $4.78M, a 48.49% decline from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for fiscal 2023 was $9.28M, a 15.02% decline from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, noncash expense for fiscal 2022 was $10.91M, a 38.17% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 1 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 55 month | Share-based Payment Arrangement, Noncash Expense 58 month | Share-based Payment Arrangement, Noncash Expense 61 month | Share-based Payment Arrangement, Noncash Expense 64 month | Share-based Payment Arrangement, Noncash Expense 67 month | Share-based Payment Arrangement, Noncash Expense 70 month | Share-based Payment Arrangement, Noncash Expense 73 month | Share-based Payment Arrangement, Noncash Expense 76 month | Share-based Payment Arrangement, Noncash Expense 79 month | Share-based Payment Arrangement, Noncash Expense 82 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $4.23M 10-Q · filed 2026-08-10 | $6.01M derived: sum of 3 quarters · filed 2026-08-10 | $7.94M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||
| 2026-03-31 | $1.97M 10-Q · filed 2026-05-11 | $3.76M derived: sum of 2 quarters · filed 2026-05-11 | $5.68M derived: sum of 3 quarters · filed 2026-05-11 | $7.11M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||
| 2025-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.71M derived: sum of 2 quarters · filed 2026-03-12 | $5.13M derived: sum of 3 quarters · filed 2026-08-10 | $6.02M 10-K · filed 2026-03-12 | |||||||||||||||
| 2025-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.35M derived: sum of 2 quarters · filed 2026-08-10 | $4.23M 10-Q · filed 2025-11-10 | $5.12M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||
| 2025-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.31M 10-Q · filed 2026-08-10 | $3.20M derived: sum of 3 quarters · filed 2026-08-10 | $4.24M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||
| 2025-03-31 | $882.00K 10-Q · filed 2026-05-11 | $1.78M derived: sum of 2 quarters · filed 2026-05-11 | $2.81M derived: sum of 3 quarters · filed 2026-05-11 | $3.97M derived: sum of 4 quarters · filed 2026-05-11 | |||||||||||||||
| 2024-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.93M derived: sum of 2 quarters · filed 2026-03-12 | $3.09M derived: sum of 3 quarters · filed 2026-03-12 | $4.78M 10-K · filed 2026-03-12 | |||||||||||||||
| 2024-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.19M derived: sum of 2 quarters · filed 2025-11-10 | $3.88M 10-Q · filed 2025-11-10 | $5.92M derived: sum of 4 quarters · filed 2025-11-10 | |||||||||||||||
| 2024-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.85M 10-Q · filed 2025-08-11 | $4.88M derived: sum of 3 quarters · filed 2025-08-11 | $6.96M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||||||
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-12 | $3.73M derived: sum of 2 quarters · filed 2025-05-12 | $5.81M derived: sum of 3 quarters · filed 2025-05-12 | $8.17M derived: sum of 4 quarters · filed 2025-05-12 | |||||||||||||||
| 2023-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $4.12M derived: sum of 2 quarters · filed 2025-03-18 | $6.48M derived: sum of 3 quarters · filed 2025-03-18 | $9.28M 10-K · filed 2025-03-18 | |||||||||||||||
| 2023-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.44M derived: sum of 2 quarters · filed 2024-11-12 | $7.24M 10-Q · filed 2024-11-12 | $9.95M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||||||
| 2023-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | $5.16M 10-Q · filed 2024-08-16 | $7.87M derived: sum of 3 quarters · filed 2024-08-16 | $10.64M derived: sum of 4 quarters · filed 2024-08-16 | |||||||||||||||
| 2023-03-31 | $2.79M 10-Q · filed 2024-05-13 | $5.51M derived: sum of 2 quarters · filed 2024-05-13 | $8.28M derived: sum of 3 quarters · filed 2024-05-13 | $11.09M derived: sum of 4 quarters · filed 2024-05-13 | |||||||||||||||
| 2022-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.48M derived: sum of 2 quarters · filed 2024-04-01 | $8.29M derived: sum of 3 quarters · filed 2024-04-01 | $10.91M 10-K · filed 2024-04-01 | |||||||||||||||
| 2022-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.58M derived: sum of 2 quarters · filed 2023-11-09 | $8.20M 10-Q · filed 2023-11-09 | $10.49M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||||||
| 2022-06-30 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $5.43M 10-Q · filed 2023-08-10 | $7.73M derived: sum of 3 quarters · filed 2023-08-10 | $10.03M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||||||||
| 2022-03-31 | $2.62M 10-Q · filed 2023-05-08 | $4.92M derived: sum of 2 quarters · filed 2023-05-08 | $7.22M derived: sum of 3 quarters · filed 2023-05-08 | $9.31M derived: sum of 4 quarters · filed 2023-05-08 | |||||||||||||||
| 2021-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $4.60M derived: sum of 2 quarters · filed 2023-03-13 | $6.69M derived: sum of 3 quarters · filed 2023-03-13 | $7.90M 10-K · filed 2023-03-13 | |||||||||||||||
| 2021-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $4.39M derived: sum of 2 quarters · filed 2022-11-07 | $5.60M 10-Q · filed 2022-11-07 | $6.47M derived: sum of 4 quarters · filed 2022-11-07 | |||||||||||||||
| 2021-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.30M 10-Q · filed 2022-08-08 | $4.17M derived: sum of 3 quarters · filed 2022-08-08 | $5.08M derived: sum of 4 quarters · filed 2022-08-08 | |||||||||||||||
| 2021-03-31 | $1.21M 10-Q · filed 2022-05-09 | $2.08M derived: sum of 2 quarters · filed 2022-05-09 | $3.00M derived: sum of 3 quarters · filed 2022-05-09 | $3.73M derived: sum of 4 quarters · filed 2022-05-09 | |||||||||||||||
| 2020-12-31 | $871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.78M derived: sum of 2 quarters · filed 2022-03-14 | $2.52M derived: sum of 3 quarters · filed 2022-03-14 | $2.88M 10-K · filed 2022-03-14 | |||||||||||||||
| 2020-09-30 | $912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.65M derived: sum of 2 quarters · filed 2021-11-08 | $2.00M 10-Q · filed 2021-11-08 | $2.36M derived: sum of 4 quarters · filed 2021-11-08 | |||||||||||||||
| 2020-06-30 | $733.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.09M 10-Q · filed 2021-08-09 | $1.45M derived: sum of 3 quarters · filed 2021-08-09 | $1.81M derived: sum of 4 quarters · filed 2021-08-09 | |||||||||||||||
| 2020-03-31 | $360.00K 10-Q · filed 2021-05-10 | $719.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.08M derived: sum of 3 quarters · filed 2021-05-10 | $1.51M derived: sum of 4 quarters · filed 2021-05-10 | |||||||||||||||
| 2019-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $721.00K derived: sum of 2 quarters · filed 2021-03-15 | $1.15M derived: sum of 3 quarters · filed 2021-03-15 | $1.46M 10-K · filed 2021-03-15 | |||||||||||||||
| 2019-09-30 | $362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $793.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.10M 10-Q · filed 2020-11-09 | $1.47M derived: sum of 4 quarters · filed 2020-11-09 | |||||||||||||||
| 2019-06-30 | $431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $736.00K 10-Q · filed 2020-08-10 | $1.10M derived: sum of 3 quarters · filed 2020-08-10 | $1.55M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||||||
| 2019-03-31 | $305.00K 10-Q · filed 2020-05-12 | $673.00K derived: sum of 2 quarters · filed 2020-05-12 | $1.12M derived: sum of 3 quarters · filed 2020-05-12 | $1.53M derived: sum of 4 quarters · filed 2020-05-12 | |||||||||||||||
| 2018-12-31 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $819.00K derived: sum of 2 quarters · filed 2020-03-24 | $1.23M derived: sum of 3 quarters · filed 2020-03-24 | $1.63M 10-K · filed 2020-03-24 | |||||||||||||||
| 2018-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $860.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.26M 10-Q · filed 2019-11-08 | $1.83M derived: sum of 4 quarters · filed 2019-11-08 | |||||||||||||||
| 2018-06-30 | $409.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $808.00K 10-Q · filed 2019-08-12 | $1.38M derived: sum of 3 quarters · filed 2019-08-12 | $1.94M derived: sum of 4 quarters · filed 2019-08-12 | |||||||||||||||
| 2018-03-31 | $399.00K 10-Q · filed 2019-05-13 | $966.00K derived: sum of 2 quarters · filed 2019-05-13 | $1.53M derived: sum of 3 quarters · filed 2019-05-13 | $2.10M derived: sum of 4 quarters · filed 2019-05-13 | |||||||||||||||
| 2017-12-31 | $567.00K 10-K · filed 2019-03-18 | $1.13M derived: sum of 2 quarters · filed 2019-03-18 | $1.70M derived: sum of 3 quarters · filed 2019-03-18 | $1.79M 10-K · filed 2019-03-18 | |||||||||||||||
| 2017-09-30 | $567.00K 10-Q · filed 2018-11-09 | $1.13M derived: sum of 2 quarters · filed 2018-11-09 | $1.48M 10-Q · filed 2018-11-09 | $2.60M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||||
| 2017-06-30 | $567.00K 10-Q · filed 2018-08-13 | $1.04M 10-Q · filed 2018-08-13 | $2.03M derived: sum of 3 quarters · filed 2018-08-13 | $2.78M derived: sum of 4 quarters · filed 2018-08-13 | |||||||||||||||
| 2017-03-31 | $567.00K 10-Q · filed 2018-05-11 | $1.47M derived: sum of 2 quarters · filed 2018-05-11 | $2.21M derived: sum of 3 quarters · filed 2018-05-11 | $2.94M derived: sum of 4 quarters · filed 2018-05-11 | |||||||||||||||
| 2016-12-31 | $899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.64M derived: sum of 2 quarters · filed 2018-03-09 | $2.37M derived: sum of 3 quarters · filed 2018-03-09 | $3.27M 10-K · filed 2018-03-09 | |||||||||||||||
| 2016-09-30 | $744.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $1.47M derived: sum of 2 quarters · filed 2017-11-06 | $2.37M 10-Q · filed 2017-11-06 | $3.37M derived: sum of 4 quarters · filed 2017-11-06 | |||||||||||||||
| 2016-06-30 | $727.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $1.62M 10-Q · filed 2017-08-11 | $2.63M derived: sum of 3 quarters · filed 2017-08-11 | $3.49M derived: sum of 4 quarters · filed 2017-08-11 | |||||||||||||||
| 2016-03-31 | $896.00K 10-Q · filed 2017-05-12 | $1.90M derived: sum of 2 quarters · filed 2017-05-12 | $2.76M derived: sum of 3 quarters · filed 2017-05-12 | $3.94M derived: sum of 4 quarters · filed 2017-05-12 | |||||||||||||||
| 2015-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $1.87M derived: sum of 2 quarters · filed 2017-04-13 | $3.04M derived: sum of 3 quarters · filed 2017-04-13 | $4.39M 10-K · filed 2017-04-13 | |||||||||||||||
| 2015-09-30 | $862.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $2.04M derived: sum of 2 quarters · filed 2016-11-10 | $3.38M 10-Q · filed 2016-11-10 | $4.38M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||||||||
| 2015-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.52M 10-Q · filed 2016-08-05 | $3.52M derived: sum of 3 quarters · filed 2016-08-05 | $4.41M derived: sum of 4 quarters · filed 2016-08-05 | |||||||||||||||
| 2015-03-31 | $1.35M 10-Q · filed 2016-05-06 | $2.35M derived: sum of 2 quarters · filed 2016-05-06 | $3.23M derived: sum of 3 quarters · filed 2016-05-06 | $3.88M derived: sum of 4 quarters · filed 2016-05-06 | |||||||||||||||
| 2014-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.88M derived: sum of 2 quarters · filed 2016-03-03 | $2.54M derived: sum of 3 quarters · filed 2016-03-03 | $3.09M 10-K · filed 2016-03-03 | |||||||||||||||
| 2014-09-30 | $884.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.53M derived: sum of 2 quarters · filed 2015-11-06 | $2.09M 10-Q · filed 2015-11-06 | $2.53M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||||
| 2014-06-30 | $651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.20M 10-Q · filed 2015-08-07 | $1.65M derived: sum of 3 quarters · filed 2016-03-03 | $2.09M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||||||
| 2014-03-31 | $553.00K 10-Q · filed 2015-05-08 | $994.00K derived: sum of 2 quarters · filed 2016-03-03 | $1.44M derived: sum of 3 quarters · filed 2016-03-03 | $1.88M derived: sum of 4 quarters · filed 2016-03-03 | $3.82M 10-Q · filed 2014-05-13 | ||||||||||||||
| 2013-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $883.00K derived: sum of 2 quarters · filed 2016-03-03 | $1.32M derived: sum of 3 quarters · filed 2016-03-03 | $1.72M 10-K · filed 2016-03-03 | $3.27M 10-K · filed 2014-03-28 | ||||||||||||||
| 2013-09-30 | $442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $884.00K derived: sum of 2 quarters · filed 2014-11-07 | $1.28M 10-Q · filed 2014-11-07 | $1.28M 10-Q · filed 2013-11-13 | $1.57M derived: sum of 4 quarters · filed 2014-11-07 | $2.83M 10-Q · filed 2013-11-13 | |||||||||||||
| 2013-06-30 | $442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $834.00K 10-Q · filed 2014-08-08 | $833.89K 10-Q · filed 2013-08-14 | $1.13M derived: sum of 3 quarters · filed 2014-08-08 | $1.47M derived: sum of 4 quarters · filed 2014-08-08 | $2.39M 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | $392.00K 10-Q · filed 2014-05-13 | $392.32K 10-Q · filed 2013-05-07 | $685.67K derived: sum of 2 quarters · filed 2014-05-13 | $1.03M derived: sum of 3 quarters · filed 2014-05-13 | $1.26M derived: sum of 4 quarters · filed 2014-05-13 | $1.94M 10-Q · filed 2013-05-07 | |||||||||||||
| 2012-12-31 | $293.67K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $636.47K derived: sum of 2 quarters · filed 2014-03-28 | $865.00K derived: sum of 3 quarters · filed 2014-03-28 | $865.00K 10-K · filed 2014-03-28 | $865.16K 10-K · filed 2013-03-11 | $1.55M 10-K/A · filed 2013-11-22 | |||||||||||||
| 2012-09-30 | $342.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $571.33K derived: sum of 2 quarters · filed 2013-11-13 | $571.33K 10-Q · filed 2013-11-13 | $867.92K derived: sum of 4 quarters · filed 2013-11-22 | $1.26M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $228.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $228.53K 10-Q · filed 2013-08-14 | $525.12K derived: sum of 3 quarters · filed 2013-11-22 | $570.29K derived: sum of 4 quarters · filed 2013-11-22 | $915.25K 10-Q · filed 2012-08-13 | ||||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-07 | $296.59K derived: sum of 2 quarters · filed 2013-11-22 | $341.76K derived: sum of 3 quarters · filed 2013-11-22 | $686.71K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $296.59K 10-K/A · filed 2013-11-22 | $341.76K derived: sum of 2 quarters · filed 2013-11-22 | $435.65K 10-K/A · filed 2013-11-22 | $686.71K 10-K · filed 2012-03-30 | |||||||||||||||
| 2011-10-31 | $139.06K 10-K/A · filed 2013-11-22 | ||||||||||||||||||
| 2011-10-06 | $45.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $139.06K 10-Q · filed 2012-11-14 | |||||||||||||||||
| 2011-09-30 | $45.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $98.83K derived: sum of 2 quarters · filed 2012-11-14 | $139.06K 10-Q · filed 2012-11-14 | ||||||||||||||||
| 2011-06-30 | $53.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $93.89K 10-Q · filed 2012-08-13 | |||||||||||||||||
| 2011-03-31 | $40.24K 10-Q · filed 2012-05-15 | ||||||||||||||||||
| 2010-12-31 | $139.88K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |